Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
Open Access
- 15 May 1997
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 16 (10) , 2851-2860
- https://doi.org/10.1093/emboj/16.10.2851
Abstract
The highly complex pattern of expression of major histocompatibility complex class II (MHC‐II) molecules determines both the immune repertoire during development and subsequently the triggering and the control of immune responses. These distinct functions result from cell type‐restricted expression, developmental control and either constitutive or inducible expression of MHC‐II genes. Yet, in these various situations, MHC‐II gene expression is always under the control of a unique transactivator, CIITA. Here we show that the CIITA gene is controlled by several distinct promoters, two of which direct specific constitutive expression in dendritic cells and B lymphocytes respectively, while another mediates γ‐interferon‐induced expression. Thus the cellular, temporal and functional diversity of MHC‐II expression is ultimately controlled by differential activation of different promoters of a single transactivator gene. This provides novel experimental tools to dissect compartment‐specific gain or loss of MHC‐II function in vivo .Keywords
This publication has 36 references indexed in Scilit:
- REGULATION OF MHC CLASS II GENES: Lessons from a DiseaseAnnual Review of Immunology, 1996
- Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling PathwayCell, 1996
- Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genesImmunology Today, 1995
- Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITAScience, 1994
- MHC Class II‐Deficient Combined Immunodeficiency: A Disease of Gene RegulationImmunological Reviews, 1994
- Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)Cell, 1993
- Sequences and Factors: A Guide to MHC Class-II TranscriptionAnnual Review of Immunology, 1992
- Sequence-Specific DNA Binding by the c-Myc ProteinScience, 1990
- Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-XCell, 1988
- A multiplicity of CCAAT box-binding proteinsCell, 1987